- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by UTC Therapeutics Inc.
Total 3421 results
-
Zhejiang UniversityUTC Therapeutics Inc.RecruitingMesothelin-positive Advanced Malignant Solid TumorsChina
-
Ruijin HospitalUTC Therapeutics Inc.RecruitingRefractory Malignant Solid NeoplasmChina
-
Changhai HospitalUTC Therapeutics Inc.RecruitingCD70-positive Advanced Urologic NeoplasmsChina
-
Peking UniversityUTC Therapeutics Inc.Not yet recruiting
-
Shanghai Pudong HospitalUTC Therapeutics Inc.WithdrawnMesothelin-positive Advanced Refractory Solid TumorsChina
-
Shanghai Pudong HospitalUTC Therapeutics Inc.WithdrawnAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | B-cell Non-Hodgkin's Lymphoma (B-NHL) | T-Cell Leukemia/Lymphoma, Adult | B-cell Acute Lymphoblastic Leukemia (B-ALL)China
-
Chinese PLA General HospitalUTC Therapeutics Inc.RecruitingAdvanced or Metastatic Solid TumorsChina
-
Chinese PLA General HospitalUTC Therapeutics Inc.RecruitingSolid Tumor, AdultChina
-
Chinese PLA General HospitalUTC Therapeutics Inc.Recruiting
-
UTC Therapeutics Inc.Peking University Cancer Hospital & InstituteRecruitingColorectal Cancer | Pancreatic Cancer | Rectal Cancer | Malignant Mesothelioma | Bile Duct Cancer | Breast Cancer Female | Ovary CancerChina
-
PTC TherapeuticsRecruitingA Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Huntington DiseaseUnited States, Austria, Spain, United Kingdom, Australia, France, Germany, Netherlands, Italy, New Zealand, Canada
-
PTC TherapeuticsCompletedNonsene Mutation Duchenne Muscular DystrophyUnited States
-
PTC TherapeuticsEnrolling by invitationInherited Mitochondrial DiseaseUnited States, France, Spain, United Kingdom, Italy, Poland, Japan
-
PTC TherapeuticsActive, not recruitingAmyotrophic Lateral SclerosisUnited States, Belgium, Spain, Australia, Germany, Italy, Czechia, France, Netherlands, Japan, Poland, Argentina, Sweden
-
PTC TherapeuticsCompletedMitochondrial Diseases | Drug Resistant Epilepsy | Leigh Disease | Leigh Syndrome | Mitochondrial Encephalopathy (MELAS) | Pontocerebellar Hypoplasia Type 6 (PCH6) | Alpers Disease | Alpers SyndromeUnited States, Spain, United Kingdom, Canada, France, Italy, Poland, Sweden, Japan
-
PTC TherapeuticsNo longer available
-
PTC TherapeuticsCompletedBH4 Deficiency | HyperphenylalaninemiaUnited States
-
PTC TherapeuticsTerminatedCOVID-19 | Pneumonia | CoronavirusSpain, United States, Australia, France, Brazil, Mexico, South Africa, Belgium, Colombia, Poland, Portugal
-
PTC TherapeuticsTerminatedLimb-Girdle Muscular DystrophyUnited States, Norway, Canada, Sweden, Russian Federation, Denmark, France, Germany
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
PTC TherapeuticsCompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | DystrophinopathyUnited Kingdom, Canada, Germany, Spain, Sweden, Italy, Australia, Belgium, France, Israel
-
PTC TherapeuticsCompletedFriedreich's AtaxiaUnited States
-
PTC TherapeuticsCompleted
-
PTC TherapeuticsTerminatedCystic FibrosisUnited States, Spain, France, Belgium, United Kingdom, Australia, Brazil, Bulgaria, Canada, Germany, Israel, Italy, Netherlands, Poland, Argentina, Greece
-
PTC TherapeuticsTerminatedCystic FibrosisUnited States, France, Spain, Belgium, Israel, Italy, Sweden
-
PTC TherapeuticsCompleted
-
PTC TherapeuticsWithdrawn
-
PTC TherapeuticsCompleted
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
UNC Lineberger Comprehensive Cancer CenterG1 Therapeutics, Inc.Recruiting
-
PTC TherapeuticsRecruitingPhenylketonuriaUnited States, Germany, Spain, Australia, Brazil, United Kingdom, Denmark, Mexico, Portugal, Turkey, Canada, Georgia, Italy, Netherlands, Japan
-
PTC TherapeuticsActive, not recruitingFriedreich AtaxiaUnited States
-
PTC TherapeuticsActive, not recruitingAADC DeficiencyUnited States, Israel, Taiwan
-
PTC TherapeuticsCompletedFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
PTC TherapeuticsCompletedLeiomyosarcomaUnited States
-
PTC TherapeuticsEnrolling by invitationDuchenne Muscular DystrophyUnited States, Canada
-
PTC TherapeuticsEnrolling by invitationFriedreich AtaxiaUnited States, Australia, Brazil, Canada, France, Germany, Italy, New Zealand, Spain
-
PTC TherapeuticsCompletedPhenylketonuriaSpain, United States, Australia, Germany, United Kingdom, Brazil, Denmark, Canada, France, Georgia, Italy, Mexico, Netherlands, Portugal, Turkey
-
PTC TherapeuticsCompletedLeigh SyndromeUnited States
-
PTC TherapeuticsCompletedDuchenne Muscular DystrophyUnited States
-
PTC TherapeuticsCompleted
-
PTC TherapeuticsCompletedNervous System Diseases | Genetic Diseases, Inborn | Genetic Diseases, X-Linked | Musculoskeletal Diseases | Muscular Diseases | Neuromuscular Diseases | Muscular Dystrophies | Muscular Disorders, Atrophic | Muscular Dystrophy, DuchenneUnited States, Spain, Korea, Republic of, Belgium, France, Canada, Australia, United Kingdom, Israel, Italy, Brazil, Chile, Czechia, Sweden, Switzerland, Turkey, Germany, Poland
-
PTC TherapeuticsWithdrawnDuchenne Muscular Dystrophy
-
PTC TherapeuticsCompletedHepatic ImpairmentUnited States
-
PTC TherapeuticsCompletedHealthy VolunteersUnited States
-
PTC TherapeuticsNot yet recruitingPhenylketonuriaUnited States
-
PTC TherapeuticsRecruitingHuntington DiseaseAustralia, France, Germany, Netherlands, United Kingdom, Spain, Austria, Canada, Italy, New Zealand
-
PTC TherapeuticsActive, not recruitingLeiomyosarcomaUnited States, United Kingdom, France, Italy, Netherlands, Spain, Australia, Canada, Brazil, Germany, Hungary, Poland